Question 1

What is Trastuzumab?

Accepted Answer

Trastuzumab is a targeted therapy classified as a monoclonal antibody. It works by identifying and binding to specific proteins called human epidermal growth factor receptor 2 (HER2) found on the surface of certain cells.

Once attached to these receptors, the medication interferes with the signals that promote cell growth and division. This mechanism is intended to inhibit the proliferation of cells that overproduce the HER2 protein.

Question 2

What is Trastuzumab used for?

Accepted Answer

Trastuzumab is used to treat HER2-positive breast cancer , HER2-positive gastric or gastroesophageal junction adenocarcinoma .

Question 3

How does Trastuzumab work?

Accepted Answer

Targeting HER2 Proteins

Some types of breast, stomach, and esophageal cancers are HER2-positive, meaning the cancer cells have an excess of a protein called human epidermal growth factor receptor 2 (HER2). These proteins act as receptors on the cell surface that send signals telling the cancer to grow and divide.

Mechanism of Action

Trastuzumab is a type of monoclonal antibody designed to interfere with the growth of these specific cancer cells. It works in two primary ways:

Blocking Signals: The medication attaches to the HER2 receptors on the surface of the cancer cells. This prevents the receptors from receiving the signals that tell the cells to multiply, which can slow or stop the tumor's growth.

Immune System Response: By binding to the cancer cells, trastuzumab may also help the body's immune system identify and destroy those cells.

This treatment is specifically targeted, meaning it is most effective against cancers that overexpress the HER2 protein.

Question 4

What are the brand names for Trastuzumab?

Accepted Answer

Trastuzumab is sold under the brand names:

Herceptin

Kanjinti

Ogivri

Question 5

What are the active ingredients in Trastuzumab?

Accepted Answer

The active ingredient in Trastuzumab is trastuzumab .

Question 6

What are the side effects of Trastuzumab?

Accepted Answer

Common side effects of Trastuzumab may include:

fever

chills

nausea

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Trastuzumab?

Accepted Answer

Trastuzumab belongs to the monoclonal antibody HER2 inhibitor drug class.

Question 8

What is the dosage of Trastuzumab and how do I take it?

Accepted Answer

Administration

Trastuzumab is given as an infusion into a vein by a healthcare provider in a medical setting, such as a hospital or clinic. It is not intended for self-administration at home.

Dosing Schedule

The frequency of your treatments will be determined by your doctor based on the condition being treated. Common schedules include receiving the medication once every week or once every three weeks.

The initial dose is typically administered slowly over a longer period to monitor for any infusion-related reactions. If the first dose is tolerated well, future doses may be given over a shorter timeframe.

Missed Dose

If you miss an appointment for an infusion, call your healthcare provider immediately to reschedule. Maintaining a consistent schedule is important for the treatment to be effective.

Question 9

Is Trastuzumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Trastuzumab can cause fetal harm when used during pregnancy. Exposure to this medication is associated with low levels of amniotic fluid, a condition known as oligohydramnios. This can result in severe complications for the developing fetus, such as:

Underdeveloped lungs

Skeletal abnormalities

Neonatal death

Patients who are able to become pregnant should use effective birth control while receiving trastuzumab and continue using it for 7 months after the final dose. If pregnancy is suspected or confirmed during this period, a healthcare provider should be notified immediately.

Breastfeeding

It is not known if trastuzumab is excreted in human breast milk. Due to the potential for serious side effects in a nursing infant, breastfeeding is generally not recommended during treatment and for 7 months following the last dose. Patients should consult with their healthcare team to determine the safest approach for their situation.

Question 10

What forms and strengths does Trastuzumab come in?

Accepted Answer

Trastuzumab is available in the following form:

Powder for solution: A dry substance that must be mixed with a sterile liquid before use.

This medication is administered as an intravenous infusion, meaning it is delivered directly into a vein. It is given by a healthcare provider in a clinical setting, such as a hospital or infusion center.

Question 11

What is the FDA approval status of Trastuzumab?

Accepted Answer

FDA Approval and Indications

Trastuzumab is approved by the U.S. Food and Drug Administration (FDA) for the treatment of cancers that overexpress the HER2 protein. Its primary approved uses include:

Adjuvant Breast Cancer: Used as part of a treatment regimen for HER2-overexpressing node-positive or node-negative breast cancer.

Metastatic Breast Cancer: Used alone or in combination with chemotherapy for patients who have not received prior treatment for metastatic disease.

Metastatic Gastric Cancer: Used in combination with chemotherapy for HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

Boxed Warnings

The FDA has issued boxed warnings for trastuzumab due to the risk of severe and potentially fatal adverse reactions. These include:

Cardiomyopathy: Trastuzumab can lead to heart failure or a significant decrease in heart function. Patients typically undergo heart function monitoring, such as an echocardiogram, before and during treatment.

Infusion Reactions: Serious and sometimes fatal reactions can occur during or within 24 hours of the infusion. Symptoms may include fever, chills, and respiratory distress.

Pulmonary Toxicity: The medication can cause severe lung issues, including interstitial pneumonitis and acute respiratory distress syndrome.

Embryo-Fetal Toxicity: Exposure to trastuzumab during pregnancy can cause low amniotic fluid levels, which may result in permanent harm or death to the fetus.

Biosimilar Status

The FDA has approved several biosimilar versions of trastuzumab. These biosimilars are highly similar to the original reference product and have no clinically meaningful differences in safety, purity, or potency. These approvals provide additional treatment options for patients with HER2-positive malignancies.

Question 12

What should I know about Trastuzumab and cost?

Accepted Answer

Factors Influencing Cost

Trastuzumab is a specialty biological medication, which generally makes it more expensive than traditional drugs. Several factors can influence the total out-of-pocket cost:

Brand vs. Biosimilar: Trastuzumab is available as the original brand-name drug and several biosimilar versions. Biosimilars are highly similar to the original product but are often available at a lower price point.

Administration Fees: Because this medication is typically administered as an intravenous infusion or injection by a healthcare professional in a clinical setting, the total cost often includes facility fees and professional administration charges.

Treatment Schedule: The frequency and duration of treatment, which vary based on the type and stage of cancer being treated, will affect the overall expense.

Insurance and Financial Assistance

Most insurance plans, including Medicare and Medicaid, provide coverage for trastuzumab when it is prescribed for FDA-approved uses. However, patients may still be responsible for copayments, coinsurance, or deductibles. Many manufacturers offer patient assistance programs or co-pay cards to help reduce the financial burden for eligible individuals. It is recommended to contact the insurance provider or the treatment facility's billing department for specific cost estimates.

Trastuzumab

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?